Depth of Response and Early Tumor Shrinkage for Predicting Clinical Outcomes in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab

Depth of Response and Early Tumor Shrinkage for Predicting Clinical Outcomes in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab

Yi-Qun Che,1 Yue Zhang,1 Kai-Ping Ou,2 Di Wang,3 Di Shen,1 Hui-Ying Liu,4 Yang Luo5 1Department of Clinical Laboratory, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, People&am...

Full description

Bibliographic Details
Main Authors: Che YQ, Zhang Y, Ou KP, Wang D, Shen D, Liu HY, Luo Y
Format: Article
Language:English
Published: Dove Medical Press 2020-09-01
Series:Cancer Management and Research
Subjects:
depth of response
early tumor shrinkage
metastatic breast cancer
trastuzumab
survival
Online Access:https://www.dovepress.com/depth-of-response-and-early-tumor-shrinkage-for-predicting-clinical-ou-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/depth-of-response-and-early-tumor-shrinkage-for-predicting-clinical-ou-peer-reviewed-article-CMAR

Similar Items